Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA)
Historical Holders from Q3 2024 to Q3 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Symbol
-
KAPA on NYSE
-
Shares outstanding
-
17,734,228
-
Price per share
-
$0.81
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
445,019
-
Total reported value
-
$505,843
-
% of total 13F portfolios
-
0%
-
Share change
-
+226,298
-
Value change
-
+$273,129
-
Number of holders
-
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
ARMISTICE CAPITAL, LLC
|
5%
|
-50%
|
$628,306
|
-$576,510
|
884,938
|
-48%
|
Armistice Capital, LLC
|
30 Jun 2025
|
As of 30 Sep 2025,
Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA) has
14
institutional shareholders
filing 13F forms.
They hold
445,019 shares.
of 17,734,228
outstanding shares (2.5%)
.
Institutional Holders of Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
445,019
|
$505,843
|
+$273,129
|
|
|
$1.17
|
14
|
|
2025 Q2
|
174,435
|
$123,288
|
-$1,296,527
|
|
|
$0.71
|
9
|
|
2025 Q1
|
1,577,246
|
$1,463,500
|
+$857,974
|
|
|
$0.94
|
8
|
|
2024 Q4
|
406,598
|
$618,272
|
+$548,969
|
|
|
$1.52
|
5
|
|
2024 Q3
|
45,320
|
$70,000
|
+$70,000
|
|
|
$1.53
|
2
|